Urticaria and its subtypes: The role of second-generation antihistamines

European Journal of Internal Medicine

Volumn 23, Issue 1, 2012, Pages 26-30

  Ortonne, Jean Paul ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Practice guidelines; Second generation antihistamines; Urticaria

Indexed keywords

CORTICOSTEROID; DESLORATADINE; FEXOFENADINE; LEVOCETIRIZINE; MIZOLASTINE; MONTELUKAST; PLACEBO; RUPATADINE; ZAFIRLUKAST;

DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MONOTHERAPY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REVIEW; TREATMENT RESPONSE; URTICARIA;

HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; URTICARIA;

EID: 83555173617     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.09.008     Document Type: Review

References (58)

1. 2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria Allergy 64 2009 1417 1426
2. M.M.A. Kozel, and R.A. Sabroe Chronic urticaria. Aetiology, management and current and future treatment options Drugs 64 2004 2515 2536 (Pubitemid 39587219)
3. M.W. Greaves Chronic urticaria N Engl J Med 332 1995 1767 1772
4. L.K. DeLong, S.D. Culler, S.S. Saini, L.A. Beck, and S.C. Chen Annual direct and indirect health care costs of chronic idiopathic urticaria. A cost analysis of 50 nonimmunosuppressed patients Arch Dermatol 144 2008 35 39 (Pubitemid 351159387)
5. B.F. O'Donnell, F. Lawlor, J. Simpson, M. Morgan, and M.W. Greaves The impact of chronic urticaria on the quality of life Br J Dermatol 136 1997 197 201 (Pubitemid 27062719)
6. J.-P. Ortonne Chronic idiopathic urticaria for the generalist Eur J Int Med 14 2003 148 157 (Pubitemid 36677609)
7. R.A. Sabroe, and M.W. Greaves The pathogenesis of chronic idiopathic urticaria Arch Dermatol 133 1997 1003 1008 (Pubitemid 27351876)
8. J.M. Cowden, M. Zhang, and P.J. Dunford The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation J Invest Dermatol 130 2010 1023 1033
9. K. Yamaura, M. Oda, and E. Suwa Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist Toxicol Sci 34 2009 427 431
10. M. Grossman, M.J. Jamieson, and W. Kirch Histamine response and local cooling in the human skin: involvement of H1- and H2-receptors Br J Clin Pharmacol 48 1999 216 222 (Pubitemid 29349458)
11. P. Schoeffter, and T. Godfraind Histamine receptors in the smooth muscle of human internal mammary artery and saphenous vein Pharmacol Toxicol 64 1989 64 71 (Pubitemid 19040253)
12. T. Zuberbier, R. Asero, and C. Bindslev-Jensen EAACI/GA2LEN/EDF/WAO - >guideline: management of urticaria Allergy 64 2009 427 1443
13. K. Weller, and M. Maurer Desloratadine inhibits human skin mast cell activation and histamine release J Invest Dermatol 129 2009 2723 2726
14. J. Ring, R. Hein, and A. Gauger Desloratadine in the treatment of chronic idiopathic urticaria Allergy 56 2001 28 32 (Pubitemid 32156195)
15. J.T. Schroeder, R.P. Schleimer, L.M. Lichtenstein, and W. Kreutner Inhibitor of cytokine generation and mediator release by human basophils treated with desloratadine Clin Exp Allergy 31 2001 1369 1377 (Pubitemid 32823873)
16. M. Caproni, W. Volpi, B. Giomi, D. Torchi, E. Del Bianco, and P. Fabbri Cellular adhesion molecules in chronic urticaria: modulation of serum levels occurs during levocetirizine treatment Br J Dermatol 155 2006 1270 1274 (Pubitemid 44730006)
17. M. Kawashima, S. Harada, and T. Tango Review of fexofenadine in the treatment of chronic idiopathic urticaria Int J Dermatol 41 2002 701 706 (Pubitemid 35252053)
18. J. Mullol, J. Bousquet, and C. Bachert Rupatadine in allergic rhinitis and chronic urticaria Allergy 63 suppl 87 2008 5 28 (Pubitemid 351389146)
19. Y.-N. Wang, H. Fang, Z.-L. Zhou, and H.-P. Yao Effect of mizolastine on release of inflammatory mediators in sensitized mice J US-China Med Sci 5 2008 7 12
20. L. Dubertret, L. Zalupca, and T. Cristodoulo Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study Eur J Dermatol 17 2007 223 228 (Pubitemid 46847786)
21. A. Gimenez-Arnau, R.M. Pujol, and S. Ianosi Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study Allergy 62 2007 539 546 (Pubitemid 46608361)
22. J.-P. Ortonne, J.-J. Grob, P. Auquier, and I. Dreyfus Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria Am J Clin Dermatol 8 2007 37 42
23. E. Nettis, M.C. Colanardi, L. Barra, A. Ferrannini, A. Vacca, and A. Tursi Levocetrizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study Br J Dermatol 154 2006 533 538 (Pubitemid 43382664)
24. A.P. Kaplan, S.L. Spector, S. Meeves, Y. Liao, S.T. Varghese, and G. Georges Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study Ann Allergy Asthma Immunol 94 2005 662 669 (Pubitemid 40847153)
25. E. Monroe, A. Finn, and P. Patel Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial J Am Acad Dermatol 48 2003 535 541 (Pubitemid 36397016)
26. J. Ring, R. Hein, A. Gauger, E. Bronsky, B. Miller and the Desloratadine Study Group Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study Int J Dermatol 40 2001 72 76 (Pubitemid 32201239)
27. F. Leynardier, C. Duarte-Risselin, and M. Murrieta Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group Eur J Dermatol 10 2000 205 211 (Pubitemid 30186559)
28. L. Dubertret, M. Murrieta Aguiles, and J. Tonet Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR study J Eur Acad Dermatol Venereol 12 1999 16 24 (Pubitemid 29132981)
29. A. Gimenez-Arnau, I. Izquierdo, and M. Maurer The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg J Eur Acad Dermatol Venereol 23 2009 1088 1091
30. A. Kapp, and W.J. Pichler Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study Int J Dermatol 45 2006 469 474
31. G. Lorette, A. Giannetti, R.S. Pereira, F. Leynadier, and M. Murrieta-Aguttes for the URTOL Study Group. One-year treatment of chronic urticaria with mizolastine: efficacy and safety J Eur Acad Dermatol Venereol 14 2000 83 90 (Pubitemid 32898944)
32. J.W. Runge, J.C. Martinez, and E.M. Caravati Histamine antagonists in the treatment of acute allergic reactions Ann Emerg Med 21 1992 237 242
33. S.S. Bleehen, S.E. Thomas, and M.W. Greaves Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study Br J Dermatol 117 1987 81 88 (Pubitemid 17096140)
34. E.W. Monroe, S.H. Cohen, J. Kalbfleisch, and C.I. Schulz Combined H1 and H2 antihistamine therapy in chronic urticaria Arch Dermatol 117 1981 404 407 (Pubitemid 11075329)
35. F. Siebenhaar, F. Degener, T. Zuberbier, P. Martus, and M. Maurer High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study J Allergy Clin Immunol 123 2009 672 679
36. E. Nettis, M.C. Colanardi, A.L. Soccio, A. Ferrannini, and A. Vacca Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study Br J Dermatol 155 2006 1279 1282 (Pubitemid 44730008)
37. M. Staevska, T. Popov, and T. Kralimarkova The effectiveness of antihistamines in up to four-times conventional doses in difficult-to-treat urticaria J Allergy Clin Immunol 125 2010 676 682
38. H.S. Nelson, R. Reynolds, and J. Mason Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria Ann Allergy Asthma Immunol 84 2000 517 522 (Pubitemid 30365414)
39. J.-J. Grob, and J.-M. Lachapelle Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes Curr Med Res Opin 24 2008 2423 2428
40. J.-J. Grob, P. Auquier, I. Dreyfus, and J.-P. Ortonne Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study J Eur Acad Dermatol Venereol 22 2008 87 93
41. H. Kim, and C. Lynde Impact of desloratadine on symptoms and quality of life in subjects with chronic idiopathic urticaria: a multicenter, practice-based study Arch Drug Info 1 2008 63 69
42. 2LEN taskforce position paper Allergy 2011 10.1111/j.1398-9995.2011.02580.x
43. J.-J. Grob, P. Auquier, I. Dreyfus, and J.-P. Ortonne How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life Allergy 64 2009 605 612
44. S.L. Spector, R. Shikiar, G. Harding, S. Meeves, and M.J. Leahy The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria Cutis 79 2007 157 162
45. A.K. Thompson, A.F. Finn, and W.F. Schoenwetter Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria J Am Acad Dermatol 43 2000 24 30 (Pubitemid 30439708)
46. N. Riedl, G. Ortiz, and A.M. Casillas A primary care guide to managing chronic urticaria J Am Acad Phys Assist 16 2003 1 3
47. C. Banfeld, S. Gupta, and M. Marino Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine Clin Pharmacokinet 41 2002 311 318 (Pubitemid 34533758)
48. K. Simpson, and B. Jarvis Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria Drugs 59 2000 301 321 (Pubitemid 30168518)
49. J.W. Slater, A.D. Zechnich, and D.G. Haxby Second-generation antihistamines: a comparative review Drugs 57 1999 31 47
50. T.O. McBayne, and O.M. Siddall Montelukast treatment of urticaria Ann Pharmacother 40 2006 939 942 (Pubitemid 43765013)
51. A. Reimers, C. Pichler, A. Helbling, W.J. Pichler, and N. Yawalkar Zafirlukast has no beneficial effects in the treatment of chronic urticaria Clin Exp Allergy 32 2002 1763 1768 (Pubitemid 35463863)
52. M.W. Greaves, and K.T. Tan Chronic urticaria: recent advances Clin Rev Allergy Immunol 33 2007 134 143 (Pubitemid 351514146)
53. G. Di Lorenzo, M.L. Pacor, and P. Mansuerto Is there a role for antileukotrienes in urticaria? Clin Exp Dermatol 31 2006 327 334
54. S.E. Bagenstose, L. Levin, and J.A. Bernstein The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results J Allergy Clin Immunol 113 2004 134 140 (Pubitemid 38096173)
55. E. Nettis, M.C. Colanardi, M.T. Pradiso, and A. Ferrannini Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study Clin Exp Allergy 34 2004 1401 1407 (Pubitemid 39233695)
56. C.E.H. Grattan, F. Humphreys on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee Guidelines for evaluation and management of urticaria in adults and children Br J Dermatol 157 2007 1116 1123 (Pubitemid 350115711)
57. M. Maurer, J.-P. Ortonne, and T. Zuberbier Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients Br J Dermatol 160 2009 633 641
58. M. Maurer, J.-P. Ortonne, and T. Zuberbier Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation Allergy 64 2009 581 588